Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ImmunityBio is a biotech company developing next-generation immunotherapies that activate the body's immune system to treat cancers and infectious diseases. Its core platforms include cytokine fusion proteins, cell therapies, and vaccine vectors, aimed at creating durable immune memory and overcoming tumor immune evasion. The company focuses on immuno-oncology, including cancer vaccines and therapies that reduce reliance on high-dose chemotherapy, serving global markets with innovative, accessible treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.